function dap(pg, width, height) { var randomId = "dapAd" + Math.floor(Math.random() * 10000000000); document.write("
"); dapMgr.enableACB(randomId, false); dapMgr.renderAd(randomId, pg, width, height); }
Skip navigation

Wal-Mart, Google, others back U.S. bill to fight 'patent trolls'

WASHINGTON (Reuters) - Dozens of major U.S. companies, including Morgan Stanley, Google, Wal-Mart and Dell, on Tuesday urged lawmakers to pass bills that they said would protect new products against "extortive demands" on patents.Full story

News Summary: Pfizer 2Q profit beats, sales fall

THE RESULTS: Pfizer's second-quarter net income more than quadrupled, mainly on the sale of its animal health business and a litigation gain. Revenue fell again, however, because of expired patents on its former blockbusters. Full story

Unwired Planet names Philip Vachon as chairman

Unwired Planet Inc., which owns patents on technologies that allow mobile devices to connect to the Internet, on Monday named Philip Vachon as chairman of its board. Full story

Sponsored Links

Articles

Pfizer will reorganize commercial operations

Court overturns patents on Teva's MS drug Copaxone

What's Behind Lilly's Solid Q2 Earnings

Senators push for quicker generic drug access

U.S. Supreme Court win boosts fight against drug settlements -FTC

Supreme Court win boosts fight against drug settlements: FTC

U.S. lawmakers offer bill to curb patent lawsuits

Patent company Eolas loses patents to web sites after appeal

Acacia shares sink after posting 2Q loss

Acacia Research posts wide loss as legal, other costs rise

Video

  SCOTUS rules on patenting human genes

A landmark decision from the Supreme Court ruled that human genes cannot be patented, but synthetic genes can. Chris Hayes and the All In panel discuss.

  Landmark Supreme Court ruling on patenting human genes

In a unanimous landmark decision Thursday, the Supreme Court ruled that human genes cannot be patented but that synthetic genes can. Chris Hayes looks at the far-reaching effects of this decision both in terms of breakthrough medical research and the costs of certain medical tests, and what the brav

  Cash, Credit or iTunes?

CNBC's Jon Fortt reports Apple now has a patent application that describes a system for coupons and payments through users' phones.

  Fortt: ITC Rules Against Apple

The ITC rules Apple violated a Samsung patent and issues a limited ban on Apple products, most of which are older. CNBC's Jon Fortt reports.

  Young inventor intros 'hamster bowling' to world

A 12-year-old Michigan girl discusses securing a patent for a new game, which she accidentally discovered when she was nine, "hamster bowling." WDIV's Brandon Roux reports.

advertisement | ad info

Related Photos

(FILES) A businessman checks his Blackbe
(FILES) A businessman checks his Blackbe

Washington, UNITED STATES: A businessman checks his Blackberry 10 February, 2006 in Washinton, DC. The Canadian manufacturer of the BlackBerry wireless e-mail handheld that made addicts of several million Americans, faces a court showdown 24 February, 2006 over a patent dispute which could cut its

Ranjit Shahani, chairman and managing director of Novartis India Ltd, speaks with media during news conference in Mumbai
Ranjit Shahani, chairman and managing director of Novartis India Ltd, speaks with media during news conference in Mumbai

Ranjit Shahani, chairman and managing director of Novartis India Ltd, speaks with the media during a news conference in Mumbai April 1, 2013. Novartis India Ltd, a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, Shahani said on Monday, after the country's top court r

Chris Viehbacher, CEO of Sanofi, attends the company's 2012 annual results presentation in Paris
Chris Viehbacher, CEO of Sanofi, attends the company's 2012 annual results presentation in Paris

Chris Viehbacher, Chief Executive Officer of Sanofi, poses for the media before the company's 2012 annual results presentation in Paris February 7, 2013. Sanofi predicted that growth would resume in the second half of 2013 once the impact of drug patent losses eases, after reporting an expected 24 p